United Therapeutics Corp
SWB:UTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
United Therapeutics Corp
SWB:UTH
|
US |
|
O
|
Oriental Land Co Ltd
XBER:OLL
|
JP |
|
Biomea Fusion Inc
NASDAQ:BMEA
|
US |
|
S
|
Sprouts Farmers Market Inc
XMUN:1FA
|
US |
|
Oatly Group AB
NASDAQ:OTLY
|
SE |
|
Creo Medical Group PLC
F:1RC
|
UK |
|
N
|
Nov Inc
XMUN:NO8
|
US |
|
P
|
Paychex Inc
F:PCX
|
US |
|
Mirait One Corp
F:5FO
|
JP |
|
S
|
Southern Co
XMUN:SOT
|
US |
|
Industria de Diseno Textil SA
MAD:ITX
|
ES |
|
Kruk SA
F:83I
|
PL |
|
M
|
Marks and Spencer Group PLC
XBER:MA6
|
UK |
|
Famous Brands Ltd
OTC:FMBRY
|
ZA |
|
A
|
AXA SA
MIL:AXA
|
FR |
|
Bank of China Ltd
F:W8VS
|
CN |
|
H
|
Huatai Securities Co Ltd
SWB:206H
|
CN |
|
Basf Se
XETRA:BAS
|
DE |
|
R
|
Ren Redes Energeticas Nacionais SGPS SA
ELI:RENE
|
PT |
|
Bridgestone Corp
OTC:BRDCY
|
JP |
|
A
|
Air China Ltd
XBER:AD2
|
CN |
|
B
|
BayWa AG
XMUN:BYW
|
DE |
|
A
|
Amata Corporation PCL
SET:AMATA
|
TH |
|
A
|
Atlantic Sapphire ASA
XBER:4AS
|
NO |
Bankruptcy Probability
United Therapeutics Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
United Therapeutics Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
23.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
175.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
United Therapeutics Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, United Therapeutics Corp has no debt.
You can find a full breakdown on its Balance Sheet.
